18 Aug 2023 by admin in UncategorizedComments Eluminex Biosciences Completes Series B+ Financing, Raising More Than $50 M in 2023
14 Aug 2023 by admin in UncategorizedComments Design Therapeutics Reports Initial Results from Phase 1 Multiple-Ascending Dose Study of DT-216 for the Treatment of Friedrich Ataxia
10 Aug 2023 by admin in UncategorizedComments Oricell OriCAR-017 CAR-T Therapy Clears IND Hurdle, Paving the Way for Global Impact
